Home » High-Quality Health Information » Health Topics » Hemolytic Anemia » Study: NCT00004412

| Print this page

• Home
• High-Quality
  Health Information
  • Health Topics
  • Health Resources
• Understanding Health Research
  • What is health research?
  • Is health research safe?
  • Is health research
    right for me?
• Health Research in Massachusetts
  • Search Ongoing Studies
  • Community-Engaged Research Projects
  • Community Health Centers

Title:	Phase II Randomized Trial of Arginine Butyrate Plus Standard Local Therapy in Patients With Refractory Sickle Cell Ulcers
Status:	Recruiting participants
Conditions:	Skin Ulcers; Sickle Cell Anemia
Interventions:	Drug: arginine butyrate
Institutions:	Boston University
Health Topics:	Hemolytic Anemia, Sickle Cell Anemia
View this study on ClinicalTrials.gov

Contact Information

---

© Community Connect to Research, 2012